Amneal to buy Actavis’ Australian generics

codeine tabsules spill from orange pill bottle
Amneal Pharmaceuticals and Actavis Australia, a subsidiary of Actavis plc today announced they have signed a binding letter of intent which provides that Amneal intends to acquire substantially all of Actavis’ in-country generic pharmaceuticals business for an agreed price, subject to completion of confirmatory due diligence and definitive agreements. Financial terms of the agreement are

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Let allied health do its job: Terry White
Next Vitamin/supplement market growing